Story perspectives
DEA Schedules Cannabis to III, Critics Barred from Testifying
6/30/2026
1 of 1
Story summary
- The Drug Enforcement Administration (DEA) will hold a cannabis rescheduling hearing June 29–July 15 in Arlington, Virginia.
- NORML chair Joseph A. Bondy and National Cannabis Industry Association chair Adam Rosenberg say the hearing bars proponents from testifying, making Schedule III an interim fix.
- Smart Approaches to Marijuana president Kevin Sabet will claim products raise health risks and that rescheduling grants tax breaks, though Dr. Patricia Hurford warns research gaps and safety concerns remain.
